Related Experiment Video
Updated: Nov 29, 2025

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
Loss of TAX1BP1-Directed Autophagy Results in Protein Aggregate Accumulation in the Brain
Shireen A Sarraf1, Hetal V Shah2, Gil Kanfer1
1Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Protein aggregates disrupt cellular homeostasis, causing toxicity linked to neurodegeneration. Selective autophagic elimination of aggregates is critical to protein quality control, but how aggregates are selectively targeted for degradation is unclear. We compared the requirements for autophagy receptor proteins: OPTN, NBR1, p62, NDP52, and TAX1BP1 in clearance of proteotoxic aggregates. Endogenous TAX1BP1 is recruited to and required for the clearance of stress-induced aggregates, whereas ectopic expression of TAX1BP1 increases clearance through autophagy, promoting viability of human induced pluripotent stem cell-derived neurons. In contrast, TAX1BP1 depletion sensitizes cells to several forms of aggregate-induced proteotoxicity. Furthermore, TAX1BP1 is more specifically expressed in the brain compared to other autophagy receptor proteins. In vivo, loss of TAX1BP1 results in accumulation of high molecular weight ubiquitin conjugates and premature lipofuscin accumulation in brains of young TAX1BP1 knockout mice. TAX1BP1 mediates clearance of a broad range of cytotoxic proteins indicating therapeutic potential in neurodegenerative diseases.
Insights
The autophagy receptor TAX1BP1 is crucial for clearing toxic protein aggregates in neurons, protecting against neurodegenerative disease. Its absence leads to aggregate buildup and neuronal damage.
Area of Science:
- Cell Biology
- Neuroscience
- Molecular Biology
Background:
- Protein aggregates disrupt cellular homeostasis and are linked to neurodegenerative diseases.
- Selective autophagic elimination of aggregates is vital for protein quality control, but the targeting mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of autophagy receptor proteins, specifically TAX1BP1, in the clearance of proteotoxic aggregates.
- To determine the therapeutic potential of TAX1BP1 in neurodegenerative diseases.
Main Methods:
- Comparison of autophagy receptor requirements (OPTN, NBR1, p62, NDP52, TAX1BP1) for aggregate clearance.
- Assessment of TAX1BP1's role in aggregate clearance in human induced pluripotent stem cell-derived neurons and TAX1BP1 knockout mouse models.
- Analysis of protein aggregate levels, ubiquitin conjugates, and lipofuscin accumulation.
Main Results:
- Endogenous TAX1BP1 is recruited to and essential for clearing stress-induced protein aggregates.
- Ectopic TAX1BP1 expression enhances aggregate clearance via autophagy, improving neuronal viability.
- TAX1BP1 depletion increases sensitivity to proteotoxicity, and its loss in vivo causes ubiquitin conjugate and lipofuscin accumulation in mouse brains.
Conclusions:
- TAX1BP1 plays a critical role in the selective autophagic clearance of proteotoxic aggregates.
- TAX1BP1 exhibits specific expression in the brain and mediates the clearance of diverse cytotoxic proteins.
- TAX1BP1 represents a potential therapeutic target for neurodegenerative diseases characterized by protein aggregate accumulation.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Lysosomal Hydrolases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

